Invention Grant
- Patent Title: LXR modulators
-
Application No.: US14774839Application Date: 2014-03-14
-
Publication No.: US09751869B2Publication Date: 2017-09-05
- Inventor: Ellen K. Kick , Mandar Bodas , Raju Mohan , Brett B. Busch , Claudia Averbuj , Meriah Valente , Nicholas Wurtz , Prasanna Savanor Maddu Rao , Jeevanprakash Shetty , Alla Venu
- Applicant: BRISTOL-MYERS SQUIBB COMPANY , Exelixis Patent Company LLC
- Applicant Address: US NJ Princeton US CA South San Francisco
- Assignee: Bristol-Myers Squibb Company,Exelixis Patent Company LLC
- Current Assignee: Bristol-Myers Squibb Company,Exelixis Patent Company LLC
- Current Assignee Address: US NJ Princeton US CA South San Francisco
- Agency: Fox Rothschild LLP
- International Application: PCT/US2014/027679 WO 20140314
- International Announcement: WO2014/152738 WO 20140925
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D405/14 ; C07D413/10 ; C07D403/10
Abstract:
The present invention provides compounds of Formula I and Formula II: or pharmaceutically acceptable salts or solvates thereof, as modulators of liver X receptors (LXRs), and compositions comprising any of such novel compounds and methods of use thereof. These compounds are useful as medicaments for treatment and/or prophylaxis for diseases or conditions related to activity of LXRs.
Public/Granted literature
- US20160289222A1 LXR MODULATORS Public/Granted day:2016-10-06
Information query
